Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

This study has been completed.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			HIV Infections
2		Additional conditions recognized in this trial
			Acquired Immunodeficiency Syndrome
			Communicable Diseases
			Infection
3		More general conditions related to this trial
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Lentivirus Infections
			Retroviridae Infections
			RNA Virus Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Viral
			Slow Virus Diseases
			Virus Diseases
4		Interventions listed in this trial
			Atazanavir
			Lamivudine/Zidovudine
			Abacavir sulfate
			Efavirenz
			Nevirapine
			Lamivudine
			Stavudine
			Zidovudine
			Didanosine
5		Additional drug interventions recognized in this trial
			Abacavir
			Dideoxynucleosides
6		More general drug interventions related to this trial
			Anti-HIV Agents
			Anti-Infective Agents
			Anti-Retroviral Agents
			Antimetabolites
			Antiviral Agents
			Enzyme Inhibitors
			HIV Protease Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Protease Inhibitors
			Reverse Transcriptase Inhibitors
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Allergy and Infectious Diseases (NIAID)